Follow-on deployment in the state builds on initial PureOne rollout announced in December SuperCom Ltd. (NASDAQ:SPCB)We ...
The Phase 1 clinical study is expected to enroll approximately 24 healthy adult volunteers. The primary objectives of the study are to characterize the pharmacokinetic release profile of the nalmefene ...
5th new project launch from the start of the new year highlights rapid follow-on expansion through established regional ...
Lexington, Massachusetts-- (Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ: ISPC), a leading provider of human biospecimens for research, is proud to announce recent milestones that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results